TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2517538
log Bayes Factor = 80.422
Chromosome 6   position 31,013,541  (GRCh37) Explore rs2517538 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
L40 Psoriasis
0.000 0.000 1.000
L40.5 Arthropathic psoriasis
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.001 0.999
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.001 0.999
E00-E07 Disorders of thyroid gland
0.000 0.002 0.998
E83.1 Disorders of iron metabolism
0.981 0.019 0.000
C61 Malignant neoplasm of prostate
0.974 0.026 0.000
C83.3 Large cell (diffuse)
0.000 0.036 0.964
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.037 0.963
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.038 0.962
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.039 0.961
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.043 0.957
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.046 0.954
C85.1 B-cell lymphoma, unspecified
0.000 0.048 0.952
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.074 0.926
E07 Other disorders of thyroid
0.000 0.092 0.908
L40.0 Psoriasis vulgaris
0.000 0.094 0.906
C81 Hodgkin's disease
0.000 0.117 0.883
E03.8 Other specified hypothyroidism
0.000 0.134 0.866
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.138 0.862
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.150 0.850
E07.9 Disorder of thyroid, unspecified
0.000 0.152 0.848
C82.3 Follicular lymphoma grade IIIa
0.000 0.177 0.822
C82.2 Large cell, follicular
0.000 0.180 0.820
C83.7 Burkitt's tumour
0.000 0.198 0.802
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.205 0.795
L40.1 Generalised pustular psoriasis
0.000 0.213 0.787
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.220 0.780
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.231 0.769
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.235 0.764
L40.8 Other psoriasis
0.000 0.236 0.764
C81.9 Hodgkin's disease, unspecified
0.000 0.257 0.743
L40.4 Guttate psoriasis
0.000 0.273 0.727
C81.1 Nodular sclerosis
0.000 0.282 0.718
L40.2 Acrodermatitis continua
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.284 0.716
E05.4 Thyrotoxicosis factitia
0.000 0.284 0.716
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.284 0.716
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.284 0.716
E00 Congenital iodine-deficiency syndrome
0.000 0.284 0.716
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.294 0.706
C81.2 Mixed cellularity
0.000 0.295 0.705
C82.0 Small cleaved cell, follicular
0.000 0.303 0.697
C85.0 Lymphosarcoma
0.000 0.310 0.690
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.310 0.690
C83.6 Undifferentiated (diffuse)
0.000 0.311 0.689
C83.4 Immunoblastic (diffuse)
0.000 0.311 0.689
C83.2 Mixed small and large cell (diffuse)
0.000 0.311 0.689
C82.6 Cutaneous follicle centre lymphoma
0.000 0.314 0.686
C82.5 Diffuse follicle centre lymphoma
0.000 0.314 0.686
E06 Thyroiditis
0.000 0.315 0.685
C86 Other specified types of T/NK-cell lymphoma
0.000 0.317 0.683
C81.0 Lymphocytic predominance
0.000 0.323 0.677
K90 Intestinal malabsorption
0.000 0.327 0.673
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.327 0.673
C84.5 Other and unspecified T-cell lymphomas
0.000 0.328 0.672
C82.4 Follicular lymphoma grade IIIb
0.000 0.335 0.665
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.346 0.654
E07.1 Dyshormogenetic goitre
0.000 0.349 0.651
E07.0 Hypersecretion of calcitonin
0.000 0.349 0.651
C94 Other leukaemias of specified cell type
0.000 0.355 0.644
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.367 0.633
C81.3 Lymphocytic depletion
0.000 0.367 0.633
C83.5 Lymphoblastic (diffuse)
0.000 0.368 0.632
C83.1 Small cleaved cell (diffuse)
0.000 0.371 0.629
E07.8 Other specified disorders of thyroid
0.000 0.374 0.626
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.375 0.625
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.375 0.625
C81.7 Other Hodgkin's disease
0.000 0.380 0.620
C93 Monocytic leukaemia
0.000 0.395 0.605
L40.3 Pustulosis palmaris et plantaris
0.000 0.408 0.592
C84.0 Mycosis fungoides
0.000 0.413 0.587
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.419 0.581
E05.8 Other thyrotoxicosis
0.000 0.419 0.580
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.424 0.576
E03.1 Congenital hypothyroidism without goitre
0.000 0.427 0.572
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.432 0.568
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.441 0.559
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.441 0.559
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.441 0.559
C84.3 Lymphoepithelioid lymphoma
0.000 0.441 0.559
C84.2 T-zone lymphoma
0.000 0.441 0.559
C84.1 Sezary's diease
0.000 0.441 0.559
C88 Malignant immunoproliferative diseases
0.000 0.461 0.539
E06.3 Autoimmune thyroiditis
0.000 0.466 0.534
K90.9 Intestinal malabsorption, unspecified
0.000 0.467 0.533
C95 Leukaemia of unspecified cell type
0.000 0.467 0.533
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.487 0.513
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.487 0.513
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.487 0.513
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.487 0.513
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.487 0.513
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.487 0.513
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.487 0.513
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.487 0.513
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.505 0.494
C96.8 Histiocytic sarcoma
0.000 0.505 0.494
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.505 0.494
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.505 0.494
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.505 0.494
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.505 0.494
C96.3 True histiocytic lymphoma
0.000 0.505 0.494
C96.2 Malignant mast cell tumour
0.000 0.505 0.494
C96.1 Malignant histiocytosis
0.000 0.505 0.494
C96.0 Letterer-Siwe disease
0.000 0.505 0.494
E06.5 Other chronic thyroiditis
0.000 0.509 0.491
E06.4 Drug-induced thyroiditis
0.000 0.509 0.491
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.509 0.491
E06.0 Acute thyroiditis
0.000 0.509 0.491
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.510 0.490
C86.4 Blastic NK-cell lymphoma
0.000 0.510 0.490
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.510 0.490
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.510 0.490
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.510 0.490
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.510 0.490
K90.8 Other intestinal malabsorption
0.000 0.515 0.485
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.517 0.483
K90.3 Pancreatic steatorrhoea
0.000 0.517 0.483
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.517 0.483
K90.1 Tropical sprue
0.000 0.517 0.483
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.469 0.531 0.000
C94.7 Other specified leukaemias
0.000 0.538 0.462
C94.5 Acute myelofibrosis
0.000 0.538 0.462
C94.4 Acute panmyelosis
0.000 0.538 0.462
C94.3 Mast cell leukaemia
0.000 0.538 0.462
C94.2 Acute megakaryoblastic leukaemia
0.000 0.538 0.462
C94.1 Chronic erythraemia
0.000 0.538 0.462
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.538 0.462
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.542 0.458
E06.1 Subacute thyroiditis
0.000 0.549 0.451
E06.9 Thyroiditis, unspecified
0.000 0.553 0.447
C84.4 Peripheral T-cell lymphoma
0.000 0.557 0.443
C93.9 Monocytic leukaemia, unspecified
0.000 0.566 0.434
C93.7 Other monocytic leukaemia
0.000 0.566 0.434
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.566 0.434
C93.2 Subacute monocytic leukaemia
0.000 0.566 0.434
C93.0 Acute monocytic leukaemia
0.000 0.566 0.434
L40-L45 Papulosquamous disorders
0.000 0.572 0.428
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.583 0.417
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.598 0.401
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.613 0.386
C88.7 Other malignant immunoproliferative diseases
0.000 0.613 0.386
C88.3 Immunoproliferative small intestinal disease
0.000 0.613 0.386
C88.2 Gamma heavy chain disease
0.000 0.613 0.386
C88.1 Alpha heavy chain disease
0.000 0.613 0.386
C95.7 Other leukaemia of unspecified cell type
0.000 0.618 0.382
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.618 0.382
C95.9 Leukaemia, unspecified
0.000 0.637 0.363
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.638 0.361
C60-C63 Malignant neoplasms of male genital organs
0.353 0.647 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.003 0.650 0.348
C93.1 Chronic monocytic leukaemia
0.000 0.650 0.349
C91 Lymphoid leukaemia
0.001 0.661 0.339
L43 Lichen planus
0.000 0.669 0.331
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.674 0.326
L42 Pityriasis rosea
0.000 0.687 0.313
C91.9 Lymphoid leukaemia, unspecified
0.000 0.691 0.309
L44 Other papulosquamous disorders
0.000 0.693 0.307
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.693 0.307
E10-E14 Diabetes mellitus
0.000 0.702 0.298
E10 Insulin-dependent diabetes mellitus
0.000 0.706 0.294
C95.0 Acute leukaemia of unspecified cell type
0.001 0.707 0.292
E40-E46 Malnutrition
0.000 0.709 0.291
E10.3 With ophthalmic complications
0.000 0.711 0.289
E10.9 Without complications
0.000 0.715 0.285
C60 Malignant neoplasm of penis
0.278 0.722 0.000
L41 Parapsoriasis
0.000 0.727 0.273
C90.1 Plasma cell leukaemia
0.002 0.727 0.272
L43.9 Lichen planus, unspecified
0.000 0.732 0.268
C90.3 Solitary plasmacytoma
0.002 0.732 0.266
E46 Unspecified protein-energy malnutrition
0.000 0.735 0.265
C63 Malignant neoplasm of other and unspecified male genital organs
0.259 0.741 0.000
C83.0 Small cell (diffuse)
0.001 0.750 0.249
E20-E35 Disorders of other endocrine glands
0.000 0.755 0.245
C91.8 Mature B-cell leukaemia Burkitt-type
0.001 0.756 0.243
C91.7 Other lymphoid leukaemia
0.001 0.756 0.243
C91.6 Prolymphocytic leukaemia of T-cell type
0.001 0.756 0.243
C91.3 Prolymphocytic leukaemia
0.001 0.756 0.243
C91.2 Subacute lymphocytic leukaemia
0.001 0.756 0.243
E24 Cushing's syndrome
0.000 0.761 0.239
L43.3 Subacute (active) lichen planus
0.000 0.762 0.238
L43.2 Lichenoid drug reaction
0.000 0.762 0.238
L43.1 Bullous lichen planus
0.000 0.762 0.238
L43.0 Hypertrophic lichen planus
0.000 0.762 0.238
E10.2 With renal complications
0.000 0.769 0.231
L43.8 Other lichen planus
0.000 0.771 0.229
C91.5 Adult T-cell leukaemia
0.001 0.776 0.224
C92 Myeloid leukaemia
0.001 0.777 0.223
E23 Hypofunction and other disorders of pituitary gland
0.000 0.777 0.223
L44.9 Papulosquamous disorder, unspecified
0.000 0.780 0.220
L44.8 Other specified papulosquamous disorders
0.000 0.780 0.220
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.780 0.220
L44.3 Lichen ruber moniliformis
0.000 0.780 0.220
L44.2 Lichen striatus
0.000 0.780 0.220
L44.1 Lichen nitidus
0.000 0.780 0.220
L44.0 Pityriasis rubra pilaris
0.000 0.780 0.220
E10.8 With unspecified complications
0.000 0.780 0.220
E24.9 Cushing's syndrome, unspecified
0.000 0.781 0.219
E12 Malnutrition-related diabetes mellitus
0.000 0.786 0.213
C60.9 Penis, unspecified
0.213 0.787 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.790 0.210
E24.0 Pituitary-dependent Cushing's disease
0.000 0.790 0.210
C60.1 Glans penis
0.209 0.790 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.791 0.208
E45 Retarded development following protein-energy malnutrition
0.000 0.791 0.208
E43 Unspecified severe protein-energy malnutrition
0.000 0.791 0.208
E42 Marasmic kwashiorkor
0.000 0.791 0.208
E41 Nutritional marasmus
0.000 0.791 0.208
E40 Kwashiorkor
0.000 0.791 0.208
C88.0 Waldenstrom's macroglobulinaemia
0.001 0.796 0.203
C60.0 Prepuce
0.203 0.797 0.000
E10.0 With coma
0.000 0.798 0.202
C60.8 Overlapping lesion of penis
0.199 0.800 0.000
C60.2 Body of penis
0.199 0.800 0.000
E10.7 With multiple complications
0.000 0.801 0.199
E24.2 Drug-induced Cushing's syndrome
0.000 0.803 0.197
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.804 0.196
L41.9 Parapsoriasis, unspecified
0.000 0.804 0.196
L41.8 Other parapsoriasis
0.000 0.804 0.196
L41.5 Retiform parapsoriasis
0.000 0.804 0.196
L41.4 Large plaque parapsoriasis
0.000 0.804 0.196
L41.3 Small plaque parapsoriasis
0.000 0.804 0.196
L41.2 Lymphomatoid papulosis
0.000 0.804 0.196
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.804 0.196
E13 Other specified diabetes mellitus
0.000 0.805 0.194
E10.6 With other specified complications
0.000 0.806 0.194
E23.7 Disorder of pituitary gland, unspecified
0.000 0.806 0.193
C63.2 Scrotum
0.192 0.808 0.000
E23.2 Diabetes insipidus
0.000 0.809 0.190
E14 Unspecified diabetes mellitus
0.000 0.811 0.189
C63.9 Male genital organ, unspecified
0.186 0.814 0.000
C63.8 Overlapping lesion of male genital organs
0.186 0.814 0.000
C63.7 Other specified male genital organs
0.186 0.814 0.000
C63.1 Spermatic cord
0.186 0.814 0.000
C63.0 Epididymis
0.186 0.814 0.000
E25 Adrenogenital disorders
0.000 0.816 0.184
E28 Ovarian dysfunction
0.000 0.816 0.184
E23.6 Other disorders of pituitary gland
0.000 0.817 0.183
E21.3 Hyperparathyroidism, unspecified
0.000 0.818 0.182
E10.4 With neurological complications
0.000 0.823 0.177
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.824 0.176
E32 Diseases of thymus
0.000 0.824 0.176
E30 Disorders of puberty, not elsewhere classified
0.000 0.824 0.176
C62 Malignant neoplasm of testis
0.176 0.824 0.000
C92.1 Chronic myeloid leukaemia
0.000 0.825 0.175
E24.8 Other Cushing's syndrome
0.000 0.829 0.171
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.829 0.171
E24.3 Ectopic ACTH syndrome
0.000 0.829 0.171
E24.1 Nelson's syndrome
0.000 0.829 0.171
E31 Polyglandular dysfunction
0.000 0.829 0.171
C91.4 Hairy-cell leukaemia
0.001 0.833 0.167
L41.1 Pityriasis lichenoides chronica
0.000 0.837 0.162
I83 Varicose veins of lower extremities
0.162 0.838 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.001 0.840 0.160
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.001 0.840 0.160
C92.3 Myeloid sarcoma
0.001 0.840 0.160
C92.2 Subacute myeloid leukaemia
0.001 0.840 0.160
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.840 0.160
E23.1 Drug-induced hypopituitarism
0.000 0.840 0.160
E26 Hyperaldosteronism
0.000 0.844 0.156
E14.3 With ophthalmic complications
0.000 0.844 0.156
E12.9 Without complications
0.000 0.847 0.153
E12.8 With unspecified complications
0.000 0.847 0.153
E12.7 With multiple complications
0.000 0.847 0.153
E12.6 With other specified complications
0.000 0.847 0.153
E12.5 With peripheral circulatory complications
0.000 0.847 0.153
E12.4 With neurological complications
0.000 0.847 0.153
E12.3 With ophthalmic complications
0.000 0.847 0.153
E12.2 With renal complications
0.000 0.847 0.153
E12.1 With ketoacidosis
0.000 0.847 0.153
E12.0 With coma
0.000 0.847 0.153
E28.3 Primary ovarian failure
0.000 0.847 0.153
E10.1 With ketoacidosis
0.000 0.847 0.153
E15 Nondiabetic hypoglycaemic coma
0.000 0.849 0.151
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.850 0.150
C92.5 Acute myelomonocytic leukaemia
0.001 0.850 0.149
E44.1 Mild protein-energy malnutrition
0.000 0.850 0.150
E44.0 Moderate protein-energy malnutrition
0.000 0.850 0.150
E10.5 With peripheral circulatory complications
0.000 0.851 0.149
C90.2 Plasmacytoma, extramedullary
0.003 0.853 0.145
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.853 0.147
E14.5 With peripheral circulatory complications
0.000 0.855 0.145
E14.8 With unspecified complications
0.000 0.857 0.143
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.859 0.141
E13.8 With unspecified complications
0.000 0.860 0.140
E13.7 With multiple complications
0.000 0.860 0.140
E13.6 With other specified complications
0.000 0.860 0.140
E13.5 With peripheral circulatory complications
0.000 0.860 0.140
E13.4 With neurological complications
0.000 0.860 0.140
E13.3 With ophthalmic complications
0.000 0.860 0.140
E13.2 With renal complications
0.000 0.860 0.140
E13.1 With ketoacidosis
0.000 0.860 0.140
E13.0 With coma
0.000 0.860 0.140
E78.0 Pure hypercholesterolaemia
0.000 0.861 0.139
E70-E90 Metabolic disorders
0.004 0.861 0.135
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.862 0.138
E21.2 Other hyperparathyroidism
0.000 0.862 0.138
E14.6 With other specified complications
0.000 0.863 0.137
E14.7 With multiple complications
0.000 0.864 0.136
E14.0 With coma
0.000 0.864 0.136
E14.4 With neurological complications
0.000 0.865 0.135
I83.0 Varicose veins of lower extremities with ulcer
0.134 0.866 0.000
C92.9 Myeloid leukaemia, unspecified
0.001 0.866 0.133
E25.9 Adrenogenital disorder, unspecified
0.000 0.868 0.132
E25.8 Other adrenogenital disorders
0.000 0.868 0.132
E28.9 Ovarian dysfunction, unspecified
0.000 0.868 0.132
E28.8 Other ovarian dysfunction
0.000 0.868 0.132
E28.1 Androgen excess
0.000 0.868 0.132
E28.0 Oestrogen excess
0.000 0.868 0.132
C92.4 Acute promyelocytic leukaemia
0.001 0.869 0.130
E83 Disorders of mineral metabolism
0.105 0.869 0.026
E50-E64 Other nutritional deficiencies
0.000 0.871 0.129
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.001 0.871 0.129
C91.0 Acute lymphoblastic leukaemia
0.001 0.873 0.126
E16 Other disorders of pancreatic internal secretion
0.000 0.873 0.127
C62.0 Undescended testis
0.126 0.874 0.000
E30.9 Disorder of puberty, unspecified
0.000 0.874 0.126
E30.8 Other disorders of puberty
0.000 0.874 0.126
E30.1 Precocious puberty
0.000 0.874 0.126
E30.0 Delayed puberty
0.000 0.874 0.126
E32.9 Disease of thymus, unspecified
0.000 0.874 0.126
E32.8 Other diseases of thymus
0.000 0.874 0.126
E32.1 Abscess of thymus
0.000 0.874 0.126
E32.0 Persistent hyperplasia of thymus
0.000 0.874 0.126
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.874 0.126
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.874 0.126
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.874 0.126
E78.8 Other disorders of lipoprotein metabolism
0.000 0.875 0.125
I83.2 Varicose veins of lower extremities with both ulcer and inflammation
0.125 0.875 0.000
E20 Hypoparathyroidism
0.000 0.876 0.123
E21.4 Other specified disorders of parathyroid gland
0.000 0.876 0.124
E14.1 With ketoacidosis
0.000 0.877 0.123
E31.9 Polyglandular dysfunction, unspecified
0.000 0.877 0.122
E31.8 Other polyglandular dysfunction
0.000 0.877 0.122
E31.1 Polyglandular hyperfunction
0.000 0.877 0.122
C92.7 Other myeloid leukaemia
0.001 0.877 0.122
C62.1 Descended testis
0.121 0.879 0.000
E89.0 Postprocedural hypothyroidism
0.000 0.879 0.121
E14.2 Withrenal complications
0.000 0.879 0.121
E13.9 Without complications
0.000 0.879 0.121
E31.0 Autoimmune polyglandular failure
0.000 0.882 0.117
E78.5 Hyperlipidaemia, unspecified
0.000 0.883 0.117
E22 Hyperfunction of pituitary gland
0.000 0.885 0.115
E23.0 Hypopituitarism
0.000 0.886 0.113
E26.9 Hyperaldosteronism, unspecified
0.000 0.888 0.112
E26.8 Other hyperaldosteronism
0.000 0.888 0.112
E26.1 Secondary hyperaldosteronism
0.000 0.888 0.112
E29 Testicular dysfunction
0.000 0.890 0.109
E28.2 Polycystic ovarian syndrome
0.000 0.890 0.110
E78.6 Lipoprotein deficiency
0.000 0.893 0.107
E89.4 Postprocedural ovarian failure
0.000 0.895 0.105
E27 Other disorders of adrenal gland
0.000 0.895 0.105
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.895 0.105
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.003 0.896 0.102
E89.2 Postprocedural hypoparathyroidism
0.000 0.896 0.104
E74 Other disorders of carbohydrate metabolism
0.002 0.899 0.099
E72 Other disorders of amino-acid metabolism
0.003 0.899 0.098
E77 Disorders of glycoprotein metabolism
0.003 0.900 0.097
E76 Disorders of glycosaminoglycan metabolism
0.003 0.900 0.097
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.003 0.900 0.097
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.003 0.900 0.097
E51 Thiamine deficiency
0.000 0.901 0.099
E65-E68 Obesity and other hyperalimentation
0.000 0.902 0.098
E61 Deficiency of other nutrient elements
0.000 0.903 0.097
E78.4 Other hyperlipidaemia
0.000 0.904 0.096
E78.2 Mixed hyperlipidaemia
0.000 0.904 0.096
E89.3 Postprocedural hypopituitarism
0.000 0.905 0.095
E73 Lactose intolerance
0.003 0.905 0.092
E83.9 Disorder of mineral metabolism, unspecified
0.076 0.906 0.019
E83.8 Other disorders of mineral metabolism
0.076 0.906 0.019
E83.2 Disorders of zinc metabolism
0.076 0.906 0.019
E83.0 Disorders of copper metabolism
0.076 0.906 0.019
E27.9 Disorder of adrenal gland, unspecified
0.000 0.906 0.094
E70 Disorders of aromatic amino-acid metabolism
0.003 0.906 0.091
E56 Other vitamin deficiencies
0.000 0.907 0.093
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.907 0.093
E63 Other nutritional deficiencies
0.000 0.907 0.093
E50 Vitamin A deficiency
0.000 0.907 0.093
E60 Dietary zinc deficiency
0.000 0.907 0.093
E59 Dietary selenium deficiency
0.000 0.907 0.093
E52 Niacin deficiency [pellagra]
0.000 0.907 0.093
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.001 0.907 0.092
E89.8 Other postprocedural endocrine and metabolic disorders
0.001 0.907 0.092
E89.5 Postprocedural testicular hypofunction
0.001 0.907 0.092
E26.0 Primary hyperaldosteronism
0.000 0.908 0.092
E78.1 Pure hyperglyceridaemia
0.000 0.909 0.091
E58 Dietary calcium deficiency
0.000 0.909 0.091
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.909 0.091
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.909 0.091
E16.4 Abnormal secretion of gastrin
0.000 0.909 0.091
E16.3 Increased secretion of glucagon
0.000 0.909 0.091
E16.1 Other hypoglycaemia
0.000 0.909 0.091
E11 Non-insulin-dependent diabetes mellitus
0.000 0.910 0.090
E84 Cystic fibrosis
0.003 0.911 0.086
E20.1 Pseudohypoparathyroidism
0.000 0.911 0.089
E20.0 Idiopathic hypoparathyroidism
0.000 0.911 0.089
E78.3 Hyperchylomicronaemia
0.000 0.911 0.088
E83.3 Disorders of phosphorus metabolism
0.079 0.912 0.009
E79 Disorders of purine and pyrimidine metabolism
0.003 0.914 0.083
E11.0 With coma
0.000 0.916 0.084
E11.1 With ketoacidosis
0.000 0.916 0.084
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.917 0.083
E22.8 Other hyperfunction of pituitary gland
0.000 0.917 0.083
E04 Other non-toxic goitre
0.000 0.917 0.083
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.917 0.082
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.001 0.918 0.082
E89.1 Postprocedural hypoinsulinaemia
0.001 0.918 0.081
E80 Disorders of porphyrin and bilirubin metabolism
0.002 0.919 0.079
E75.5 Other lipid storage disorders
0.002 0.921 0.077
E29.8 Other testicular dysfunction
0.000 0.921 0.079
E29.0 Testicular hyperfunction
0.000 0.921 0.079
E20.8 Other hypoparathyroidism
0.001 0.921 0.078
E54 Ascorbic acid deficiency
0.000 0.921 0.078
E34 Other endocrine disorders
0.001 0.923 0.076
E61.2 Magnesium deficiency
0.000 0.923 0.077
E51.2 Wernicke's encephalopathy
0.000 0.923 0.077
E27.5 Adrenomedullary hyperfunction
0.000 0.924 0.076
E27.0 Other adrenocortical overactivity
0.000 0.924 0.076
E74.3 Other disorders of intestinal carbohydrate absorption
0.001 0.924 0.074
E14.9 Without complications
0.000 0.925 0.075
E75.6 Lipid storage disorder, unspecified
0.002 0.925 0.073
E75.4 Neuronal ceroid lipofuscinosis
0.002 0.925 0.073
E75.3 Sphingolipidosis, unspecified
0.002 0.925 0.073
E75.2 Other sphingolipidosis
0.002 0.925 0.073
E75.1 Other gangliosidosis
0.002 0.925 0.073
E75.0 GM2 gangliosidosis
0.002 0.925 0.073
Z51.3 Blood transfusion without reported diagnosis
0.000 0.926 0.074
E72.0 Disorders of amino-acid transport
0.002 0.926 0.072
E88 Other metabolic disorders
0.003 0.926 0.071
E21.0 Primary hyperparathyroidism
0.000 0.927 0.073
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.927 0.073
E74.9 Disorder of carbohydrate metabolism, unspecified
0.002 0.927 0.071
E74.8 Other specified disorders of carbohydrate metabolism
0.002 0.927 0.071
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.002 0.927 0.071
E74.2 Disorders of galactose metabolism
0.002 0.927 0.071
E74.1 Disorders of fructose metabolism
0.002 0.927 0.071
E72.9 Disorder of amino-acid metabolism, unspecified
0.002 0.927 0.071
E72.8 Other specified disorders of amino-acid metabolism
0.002 0.927 0.071
E72.5 Disorders of glycine metabolism
0.002 0.927 0.071
E72.4 Disorders of ornithine metabolism
0.002 0.927 0.071
E72.3 Disorders of lysine and hydroxylysine metabolism
0.002 0.927 0.071
E72.2 Disorders of urea cycle metabolism
0.002 0.927 0.071
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.002 0.927 0.071
E71.3 Disorders of fatty-acid metabolism
0.002 0.928 0.070
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.002 0.928 0.070
E71.1 Other disorders of branched-chain amino-acid metabolism
0.002 0.928 0.070
E71.0 Maple-syrup-urine disease
0.002 0.928 0.070
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.002 0.928 0.070
E76.8 Other disorders of glucosaminoglycan metabolism
0.002 0.928 0.070
E76.3 Mucopolysaccharidosis, unspecified
0.002 0.928 0.070
E76.2 Other mucopolysaccharidoses
0.002 0.928 0.070
E76.1 Mucopolysaccharidosis, type II
0.002 0.928 0.070
E76.0 Mucopolysaccharidosis, type I
0.002 0.928 0.070
E77.9 Disorder of glycoprotein metabolism, unspecified
0.002 0.928 0.070
E77.8 Other disorders of glycoprotein metabolism
0.002 0.928 0.070
E77.1 Defects in glycoprotein degradation
0.002 0.928 0.070
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.002 0.928 0.070
E29.9 Testicular dysfunction, unspecified
0.000 0.929 0.071
E51.9 Thiamine deficiency, unspecified
0.000 0.929 0.071
E51.8 Other manifestations of thiamine deficiency
0.000 0.929 0.071
E51.1 Beriberi
0.000 0.929 0.071
E74.0 Glycogen storage disease
0.002 0.929 0.069
E67 Other hyperalimentation
0.000 0.929 0.070
E68 Sequelae of hyperalimentation
0.000 0.929 0.070
E22.1 Hyperprolactinaemia
0.000 0.930 0.070
E61.9 Deficiency of nutrient element, unspecified
0.000 0.930 0.070
E61.8 Deficiency of other specified nutrient elements
0.000 0.930 0.070
E61.7 Deficiency of multiple nutrient elements
0.000 0.930 0.070
E61.6 Vanadium deficiency
0.000 0.930 0.070
E61.5 Molybdenum deficiency
0.000 0.930 0.070
E61.4 Chromium deficiency
0.000 0.930 0.070
E61.3 Manganese deficiency
0.000 0.930 0.070
E61.0 Copper deficiency
0.000 0.930 0.070
E73.8 Other lactose intolerance
0.002 0.932 0.066
E73.1 Secondary lactase deficiency
0.002 0.932 0.066
E73.0 Congenital lactase deficiency
0.002 0.932 0.066
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.002 0.932 0.065
E70.8 Other disorders of aromatic amino-acid metabolism
0.002 0.932 0.065
E70.2 Disorders of tyrosine metabolism
0.002 0.932 0.065
E70.1 Other hyperphenylalaninaemias
0.002 0.932 0.065
E70.0 Classical phenylketonuria
0.002 0.932 0.065
E11.6 With other specified complications
0.000 0.932 0.067
E56.1 Deficiency of vitamin K
0.000 0.933 0.067
E56.9 Vitamin deficiency, unspecified
0.000 0.933 0.067
E56.8 Deficiency of other vitamins
0.000 0.933 0.067
E56.0 Deficiency of vitamin E
0.000 0.933 0.067
E50.9 Vitamin A deficiency, unspecified
0.000 0.933 0.067
E50.8 Other manifestations of vitamin A deficiency
0.000 0.933 0.067
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.933 0.067
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.933 0.067
E50.5 Vitamin A deficiency with night blindness
0.000 0.933 0.067
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.933 0.067
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.933 0.067

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.